{
    "afe67693-c378-342f-83ed-48ea80078215": {
        "uuid": "afe67693-c378-342f-83ed-48ea80078215",
        "title": "J&J, AbbVie cancer drug significantly slows progression of rare lymphoma -study",
        "publisher": "Reuters",
        "link": "https://finance.yahoo.com/news/j-j-abbvie-cancer-drug-120000043.html",
        "providerPublishTime": 1654257600,
        "type": "STORY"
    },
    "342affb6-edba-336e-8db6-6d3a5cf89b4e": {
        "uuid": "342affb6-edba-336e-8db6-6d3a5cf89b4e",
        "title": "Can Value ETFs Continue to Outperform Growth?",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/value-etfs-continue-outperform-growth-182306611.html",
        "providerPublishTime": 1654194186,
        "type": "STORY"
    },
    "64d43813-fa3f-35a0-bdd4-989f8606416b": {
        "uuid": "64d43813-fa3f-35a0-bdd4-989f8606416b",
        "title": "UPDATE 2-Bristol Myers, J&J drugs reduce COVID death rates in NIH study",
        "publisher": "Reuters",
        "link": "https://finance.yahoo.com/news/1-bristol-myers-j-j-160353337.html",
        "providerPublishTime": 1654185833,
        "type": "STORY"
    },
    "945e096e-11cf-3f1e-a300-deae913d33bf": {
        "uuid": "945e096e-11cf-3f1e-a300-deae913d33bf",
        "title": "Is J&J Stock A Buy After Throwing Off The Covid Vaccine Shackles?",
        "publisher": "Investor's Business Daily",
        "link": "https://finance.yahoo.com/m/945e096e-11cf-3f1e-a300-deae913d33bf/is-j%26j-stock-a-buy-after.html",
        "providerPublishTime": 1654184704,
        "type": "STORY"
    },
    "ac80be6a-3f49-3ad4-bc2a-a8fea52a0165": {
        "uuid": "ac80be6a-3f49-3ad4-bc2a-a8fea52a0165",
        "title": "Here Are 6 Stocks That Pay a Lot in Dividends and Have Solid Yields. And Microsoft and Apple.",
        "publisher": "Barrons.com",
        "link": "https://finance.yahoo.com/m/ac80be6a-3f49-3ad4-bc2a-a8fea52a0165/here-are-6-stocks-that-pay-a.html",
        "providerPublishTime": 1654180200,
        "type": "STORY"
    },
    "a6be7396-5a64-3ab1-a5e7-c3578b723504": {
        "uuid": "a6be7396-5a64-3ab1-a5e7-c3578b723504",
        "title": "Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/johnson-johnson-jnj-dips-more-214509710.html",
        "providerPublishTime": 1654119909,
        "type": "STORY"
    },
    "d9abb4d5-15d6-3617-afdf-d3a447045bd1": {
        "uuid": "d9abb4d5-15d6-3617-afdf-d3a447045bd1",
        "title": "J&J's Interest in Boston Scientific Is Resurfacing",
        "publisher": "GuruFocus.com",
        "link": "https://finance.yahoo.com/news/j-js-interest-boston-scientific-192534822.html",
        "providerPublishTime": 1654111534,
        "type": "STORY"
    },
    "699ca175-4910-46e9-967e-ac13bbfb32a6": {
        "uuid": "699ca175-4910-46e9-967e-ac13bbfb32a6",
        "title": "COVID vaccines: Novavax says India, Europe, South Korea to supply global doses for 2022",
        "publisher": "Yahoo Finance",
        "link": "https://finance.yahoo.com/news/covid-vaccines-novavax-says-india-europe-south-korea-to-supply-global-doses-for-2022-174214424.html",
        "providerPublishTime": 1654105334,
        "type": "STORY"
    }
}